U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020155

Expand all

VIDEX (DIDANOSINE)
100MG/PACKET
Marketing Status: Discontinued
Active Ingredient: DIDANOSINE
Proprietary Name: VIDEX
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 100MG/PACKET
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020155
Product Number: 003
Approval Date: Oct 9, 1991
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIDEX (DIDANOSINE)
167MG/PACKET
Marketing Status: Discontinued
Active Ingredient: DIDANOSINE
Proprietary Name: VIDEX
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 167MG/PACKET
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020155
Product Number: 004
Approval Date: Oct 9, 1991
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIDEX (DIDANOSINE)
250MG/PACKET
Marketing Status: Discontinued
Active Ingredient: DIDANOSINE
Proprietary Name: VIDEX
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 250MG/PACKET
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020155
Product Number: 005
Approval Date: Oct 9, 1991
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
Marketing Status:  Discontinued
Patent and Exclusivity Information
VIDEX (DIDANOSINE)
375MG/PACKET
Marketing Status: Discontinued
Active Ingredient: DIDANOSINE
Proprietary Name: VIDEX
Dosage Form; Route of Administration: FOR SOLUTION; ORAL
Strength: 375MG/PACKET
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020155
Product Number: 006
Approval Date: Oct 9, 1991
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top